IP Library Granted Patent US 8,642,320
Granted Patent B2
US 8,642,320 · App. 12/580,866 · Granted Feb 4, 2014

Non-precipitating bodily fluid analysis system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,642,320
App. No.
12/580,866
Granted
Feb 4, 2014
Kind
B2
Abstract

A bodily fluid analyzer including a dry test strip impregnated with a reagent providing a non-precipitating reaction to exclude non-desired analytes. The reagent complexes the non-desired analytes so they remain in solution but cannot participate in the test reaction. Red blood cells are removed from the detection area by slowing their vertical movement and stopping flow when the detection membrane is saturated.

Claims (13)

1. A dry test strip for determining a characteristic of a selected analyte in blood, said dry test strip comprising:

a reaction layer including chemicals that will react with said blood to determine a characteristic of a selected analyte in said blood, the reaction layer oriented under the blood separation layer, wherein the red blood cells are slowed or stopped from reaching said reaction layer; and

said dry test strip further containing complexing chemicals that complex one or more non-selected analytes to prevent them from participating in said reaction without precipitating them, wherein said selected analyte is low density lipoprotein, said complexing chemicals including dextran sulphate, a divalent metal, and a destabilizing compound and wherein the complexing chemicals are added prior to the reaction layer.

2. A dry test strip as in claim 1 wherein said destabilizing compound is selected from the group consisting of glycols, polypropylenes, and polyethylenes.

3. A dry test strip as in claim 1 wherein said destabilizing compound is a polyoxyethylene-polyoxypropylene-polyoxyethylene hybrid.

4. A dry test strip as in claim 3 wherein said destabilizing compound has a molecular weight between 2,100 and 6,000.

5. A dry test strip as in claim 3 wherein said destabilizing compound has a preponderance of polyoxyethylene.

6. A dry test strip as in claim 1 wherein said complexing chemicals include a gentle surfactant.

7. A dry test strip as in claim 1 wherein said complexing chemicals include 3-{[3-Cholamidopropyl]dimethylammonio}3-propane-sulfonate.

8. A dry test strip as in claim 1 wherein the complexing chemicals are introduced above the reaction layer, such that as the complexed and non-selected analytes flow through the test strip, they are slowed or retained.

9. A dry test strip as in claim 1 wherein said dextran sulfate has a molecular weight between 50,000 and 8,000.

10. A dry test strip as in claim 1 wherein said dextran sulfate has a molecular weight between 25,000 and 10,000.

11. A dry test strip as in claim 1 wherein said dextran sulfate has a molecular weight between 18,000 and 12,000.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2023
From: PNC BANK, NATIONAL ASSOCIATION
To: POLYMER TECHNOLOGY SYSTEMS, INC.
Reel/Frame 062496/0115 →
SECURITY AGREEMENT Recorded Jan 19, 2012
From: POLYMER TECHNOLOGY SYSTEMS, INC.
To: PNC BANK, NATIONAL ASSOCIATION
Reel/Frame 027557/0459 →